Zobrazeno 1 - 10
of 322
pro vyhledávání: '"T, De La Motte Rouge"'
Autor:
C Cheneau, S Barthier, J Lemonnier, Fabrice Andre, C Dubot, L Teixeira, A Escande, T De La Motte Rouge, T Petit, L Arnould, Laurent Arnould, Suzette Delaloge, Jerome Lemonnier, A Marti, L Stefani, F Berger, C Levy, P Barthelemy, S Nguyen, M Gardner, A Lortholary, François-Clément Bidard, J Plaza, L Joly, Thibault de la Motte Rouge, F Andre, I Bièche, C Alleaume, R Sabatier, B Lucas, Ivan Bieche, O Derbel, L Venat-Bouvet, F Del Piano, Florian Clatot, Anne-Claire Hardy-Bessard, Frédérique Berger, Margaux Marce, Thomas Bachelot, Anne Pradines, Jean-Luc Canon, Sandrine Marques, M Achille, H Ammarguellat, O Arsene, T Bachelot, C Bernard-Marty, F-C Bidard, N Bonichon-Lamichhane, N Bonnin, R Bouaita, A Boudrant, V-A Brunel, C Chakiba, F Clatot, F Dalenc, A De Gramont, L Deiana, C Delbaldo, V Delecroix, H Desclos, V D'Hondt, N Dohollou, J-M Ferrero, C Foa, J-S Frenel, C Garnier Tixidre, D Genet, O Gisserot, M Gozy, C Greilsamer, J Grenier, F Guinet, A-C Hardy-Bessard, J-P Jacquin, E Lachaier, S Ladoire, A-P Laurenty, R Le Scodan, N Leduc, E Legouffe, C Levache, F Lorchel, N Marques, J Medioni, A Melis, D Mille, D Mollon, L Moreau, I Moullet, M-A Mouret-Reynier, A Najem, H Orfeuvre, J-F Paitel, B Pistilli, C Riedl, P Soulie, D Spaeth, F Trouboul, C Valmar, H Vegas, A Zannetti, FC Bidard, S Delaloge, A Pradines, JL Canon, S Marques
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction The combination of a CDK4/6 inhibitor with an aromatase inhibitor (AI) has recently become the gold standard for AI-sensitive first line treatment of oestrogen receptor-positive (ER+) HER2-negative (HER2−) advanced breast cancer. Howev
Externí odkaz:
https://doaj.org/article/8faf6bbc845f4ceeb90674dd08e198da
Autor:
J.-S. Frenel, A. Lusque, S. Delaloge, J.-M. Ferrero, T. Bachelot, I. Desmoulins, C. Levy, J.-C. Eymard, A. Gonçalves, A. Patsouris, M. A. Mouret Reynier, M. J.-C. Thery, T. Petit, L. Cabel, L. Uwer, M. Debled, M. Chevrot, A. Mailliez, W. Jacot, T. de La Motte Rouge
Publikováno v:
British Journal of Cancer. 128:2072-2080
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40812445ccdae72ddca53e16aa782a79
https://doi.org/10.1038/s41416-023-02248-4
https://doi.org/10.1038/s41416-023-02248-4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. Bello Roufai, A. Gonçalves, T. De La Motte Rouge, S. Akla, C. Blonz, J. Grenier, J. Gligorov, M. Saghatchian, C. Bailleux, H. Simon, I. Desmoulins, Z. Tharin, E. Renaud, M. Bertho, M-A Benderra, S. Delaloge, L. Robert, P. Cottu, J. Y. Pierga, D. Loirat, A. Bertucci, B. Renouf, F. C. Bidard, F. Lerebours
Publikováno v:
Oncogene.
SOLAR-1 and BYLieve trials documented the efficacy of the PI3K-inhibitor alpelisib in pre-treated PIK3CA-mutant, hormone receptor-positive, HER2-negative (HR+/HER2-) advanced breast cancer (ABC) patients. We report here real-life datda of patients pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdba2c376550828211ea840012464bf3
https://doi.org/10.1038/s41388-022-02585-3
https://doi.org/10.1038/s41388-022-02585-3
Autor:
L Perrier, O Tredan, M Morelle, N Penel, P Fournel, L Greillier, F Ghiringhelli, D Tosi, F Bertucci, M Campone, JP Delord, D Pouessel, G Garin, S Chabaud, C Gomez-Roca, D Pannier, M Brahmi, M Fabbro, ME Garcia, I Ray-Coquard, M Viala, A Italiano, P Cassier, A Dufresne, V Attignon, I Treilleux, A Viari, T de la Motte Rouge, X Durando, D Perol, JY Blay
Publikováno v:
ISPOR Europe 2022
ISPOR Europe 2022, Nov 2022, Vienne (Austria), Austria. 25 (12), pp.S175, 2022, ⟨10.1016/j.jval.2022.09.847⟩
ISPOR Europe 2022, Nov 2022, Vienne (Austria), Austria. 25 (12), pp.S175, 2022, ⟨10.1016/j.jval.2022.09.847⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99820299c75a22fa71f446acf858118
https://shs.hal.science/halshs-03961247
https://shs.hal.science/halshs-03961247
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Sallée, T. de la Motte Rouge, A. Lacorre, Elise Larouzee, M. Koskas, E. Chereau, E. Gauroy, Tristan Gauthier, F. Margueritte
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 48:248-259
Resume Objectif Evaluer l’epidemiologie et les facteurs de risque de recidive et les modalites de surveillance en cas de tumeur frontiere de l’ovaire (TFO) ainsi que l’interet d’une chirurgie de cloture dans le cadre des recommandations pour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::371939a867c6cbc2bb7bb3efebc0db62
https://doi.org/10.1016/j.gofs.2020.01.013
https://doi.org/10.1016/j.gofs.2020.01.013
Autor:
A. Lacorre, M. Koskas, T. de la Motte Rouge, E. Chereau, Elise Larouzee, C. Sallée, E. Gauroy, Tristan Gauthier, F. Margueritte
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie. 48:314-321
Resume Objectif Editer des recommandations pour le diagnostic et la prise en charge des recidives de tumeurs frontieres de l’ovaire (TFO). Methode Revue de la litterature interrogeant les bases Medline, Pubmed et Cochrane. Resultats En cas de TFO,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b14ae8455593b5c91f4c689698ea9c82
https://doi.org/10.1016/j.gofs.2020.01.019
https://doi.org/10.1016/j.gofs.2020.01.019
Autor:
I. Vergote, A. González-Martín, I. Ray-Coquard, P. Harter, N. Colombo, P. Pujol, D. Lorusso, M.R. Mirza, B. Brasiuniene, R. Madry, J.D. Brenton, M.G.E.M. Ausems, R. Büttner, D. Lambrechts, M. Ausems, J. Brenton, M. Abreu, S. Balboni, S. Banerjee, M. Barberis, M.P. Barretina Ginesta, J.-F. Baurain, M. Bignami, L. Bjorge, P. Blecharz, I. Bruchim, M. Capilna, N. Cerana, A. Cicchetti, D. Collins, N. Concin, M. D’Incalci, B. Davidson, T. de la Motte Rouge, P. De Iaco, F. Demirkiran, H. Denys, T. Doerk, A. Dorum, A. Ferrero, A.P. Fidalgo, M. Genuardi, L. Gladieff, R. Glasspool, C. Grimm, M. Gultekin, E. Hahnen, A. Hasenburg, A. Hegmane, V. Heinzelmann, E. Hogdall, R. Janavicius, S. Jarmalaite, R. Kalachand, R. Kaneva, S. Kilickap, R. Kocian, D. Kolencik, R. Kristeleit, A. Kryzhanivska, A. Leary, B. Lemley, M. Ligtenberg, J.A. López-Guerrero, C.J. Lord, E. Avall-Lundqvist, J. Maenpaa, S. Mahner, F. Marmé, C. Marth, I. McNeish, S. Merkelbach-Bruse, M. Mourits, N. Normanno, A. Oaknin, K. Ojamaa, C. Papdimitriou, F. Penault-Llorca, A.M. Perrone, S. Pignata, E. Pikarsky, E. Rouleau, M. Rubio, A. Sapino, B. Schmalfeldt, J. Sehouli, R. Shapira, K.D. Steffensen, V. Sukhin, J. Syrios, Z. Szallasi, C. Taskiran, M. Terzic, M. Tischkowitz, I. Toth, K. Van de Vijver, M.A. Vardar, B. Wasag, P. Wimberger, E. Witteveen
Publikováno v:
Annals of Oncology, 33, 3, pp. 276-87
Vergote, I, González-Martín, A, Ray-Coquard, I, Harter, P, Colombo, N, Pujol, P, Lorusso, D, Mirza, M R, Brasiuniene, B, Madry, R, Brenton, J D, Ausems, M G E M, Büttner, R, Lambrechts, D, European experts’ consensus group & Dahl Steffensen, K 2022, ' European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer ', Annals of Oncology, vol. 33, no. 3, pp. 276-287 . https://doi.org/10.1016/j.annonc.2021.11.013
ANNALS OF ONCOLOGY
Annals of Oncology, 33, 276-87
Vergote, I, González-Martín, A, Ray-Coquard, I, Harter, P, Colombo, N, Pujol, P, Lorusso, D, Mirza, M R, Brasiuniene, B, Madry, R, Brenton, J D, Ausems, M G E M, Büttner, R, Lambrechts, D, European experts’ consensus group & Dahl Steffensen, K 2022, ' European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer ', Annals of Oncology, vol. 33, no. 3, pp. 276-287 . https://doi.org/10.1016/j.annonc.2021.11.013
ANNALS OF ONCOLOGY
Annals of Oncology, 33, 276-87
BACKGROUND: Homologous recombination repair (HRR) enables fault-free repair of double-stranded DNA breaks. HRR deficiency is predicted to occur in around half of high-grade serous ovarian carcinomas. Ovarian cancers harbouring HRR deficiency typicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048b3ea84583ffb10df0f113446b4777